Molecular Cancer Research · 2019 · 20 citations · 15 references
MedicineCell BiologyOncologyCell SignalingMetastasisMolecular OncologyCancer Cell SignalingCancer ProgressionCancer Stem Cell BiologyCancer Stem CellsCell Cycle SignalingOncogenic Signaling PathwaysCancer Signaling PathwaysCancer Stem Cell Signaling PathwaysCancer Stem-like CellsCell Cycle InhibitionCell Cycle InhibitorsP21 PathwayP21 RegulationTumor Initiating Cells
Cancer stem cells (CSC) generate and sustain tumors due to tumor-initiating potential, resulting in recurrence or metastasis. We showed that knockout of the cell-cycle inhibitor, p21CIP1, in the PyMT mammary tumor model inhibits metastasis; however the mechanism remained unknown. Here, we show a pivotal role for p21 in potentiating a cancer stem-like phenotype. p21 knockout in PyMT mammary tumor cells caused dramatic suppression of CSC properties involving tumorsphere formation, ALDH1 activity, and tumor-initiating potential, which were in turn rescued by p21 overexpression into PyMT/p21 knockout cells. Interestingly, p21 knockout dramatically suppresses Wnt/β-catenin signaling activity, leading to striking inhibition of LEF1 and TCF1 expression. TCF1 knockdown in PyMT cells suppressed tumorsphere formation due to Cyclin D1 attenuation. These data demonstrate that p21 promotes a CSC-like phenotype via activation of Wnt/TCF1/Cyclin D1 signaling. IMPLICATIONS: p21 is a strong promoter of mammary CSCs.
15
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang, Yuji Mishina, Shanming Liu et al. · Nature · 2009 · 2.1K citations
Hematopoietic Stem Cell Quiescence Maintained by p21 <sup>cip1/waf1</sup>
Tao Cheng, Neil P. Rodrigues, Hongmei Shen et al. · Science · 2000 · 1.3K citations
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Wenjun Guo, Zuzana Keckesova, Joana Liu Donaher et al. · Cell · 2012 · 979 citations · Full text